Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI2006277 |
Pages: 92 |
Jan 2023 |
Breast imaging is a diagnostic technique used to identify the lesions which are an indication of cancer cells in the breast. Breast imaging is usually done prior to biopsy. Breast imaging process will capture images of breasts for the identification of breast cancers and has undergone many advancements in the last decade. It uses low energy X-rays to screen and identify any presence of calcifications and hard masses in the breast, which will detect cancer in early stages.
Breast cancer is foreseen to ascend with drastic changes in lifestyle, and the diminishing habit of breastfeeding, particularly in developed nations. Consequently, the demand for these imaging products is predicted to drive the market in the forecast period. Innovative advancements, such as molecular breast imaging, optical imaging, digital mammogram, electrical impedance imaging, and tomosynthesis, are currently accelerating the market growth. Government initiatives are predicted to drive the market in the forecast period. For instance, awareness generating projects and providing funding for R&D in the field of breast cancer are foreseen to support the breast cancer market. The National Cancer Institute of the U.S. contributed around 559 million on the research of breast cancer in 2013, though, in 2013, the UK government initiated a campaign "Be clear on cancer," which helped in spreading awareness and knowledge about the hazardous factors, preventive measures, and early detection of breast cancer.
Radiation dose management, product recalls stringent regulatory policies, growing adoption of refurbished systems, and errors in breast cancer screening are predicted to hinder the market growth in the forecasted period.
The greatest opportunity in the breast imaging market is the latest advancements in technology in medical sector. The rise in investments from both the non-government organizations and governments is leading the demand in the market. Globalization and urbanization are the factors that are boosting the growth opportunities in breast imaging market. The extended R&D trials, increased spending on healthcare and advanced equipment in the hospitals and diagnostic centres are the opportunities that the investors can seize in the forecasted period.
The technology segment is divided into ionizing and non-ionizing technologies. The ionizing technology is further sub-divided into segments such as full-field digital mammography, electric impedance tomography, cone-beam computed tomography, position emission tomography, position emission mammography and computed tomography (PET-CT), 3D breast tomosynthesis, analog mammography and molecular breast specific gamma imaging. The non-ionizing technology segment includes breast MRI, breast thermography, optical imaging, breast ultrasound, computerized whole-breast ultrasound. The mammography-based devices currently contributed most to the market with a major market share. But, the tomosynthesis is expected to be a lucrative segment in the expected period due to its higher precision and reliable results. Tomosynthesis takes numerous pictures of the breast simultaneously in few seconds. While the mammography devices cannot take numerous images in such a short time due to which tomosynthesis is predicted to drive the market in the forecast period.
North America region is predicted to have the highest revenue generating market in the forecast period. The advanced healthcare infrastructure in this region and the presence of repayment facilities over clinical treatments, encouraged the use of breast imaging instruments. In addition, the decent of the chronic diseases in this region is considerably higher than the worldwide normal, which is contributing to the development of this region profoundly. The Asia Pacific market is expected to observe the quickest growth in the estimated period. Strong government regulation helps to improve the health care facilities alongside financial support is predicted to drive the regional market in the forecast period.
The major market players in breast imaging are GE Healthcare, Hologic, Inc., Gamma Medica, Inc., Philips Healthcare, Fujifilm Holdings Corp., SonoCine, Inc., Toshiba Corporation, Dilon Technologies, Inc., Siemens Healthcare, and Aurora Imaging Technology, Inc.
|
Aspect |
Particulars |
|
Historical Market Estimations |
2018-2019 |
|
Base Year for Market Estimation |
2019 |
|
Forecast timeline for Market Projection |
2020-2027 |
|
Geographical Scope |
North America, Europe, Asia Pacific, and LAMEA |
|
Segmentation by Technology |
|
|
Key Countries Covered |
U.S. Canada, Germany, France, Spain, Russia, Japan, China, India, South Korea, Australia, Brazil, Latin America, Middle East, and Africa. |
|
Key Companies Profiled |
|
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization